Dr. Mossad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
G21-room 131
Cleveland, OH 44195Phone+1 216-445-2572Fax+1 216-445-9446
Summary
- Dr. Sherif Mossad is an Infectious Disease specialist based in Cleveland, OH, with subspecialties in transplant and immunocompromised states. He completed his medical education at Cairo University School of Medicine and pursued residency and fellowship at the Cleveland Clinic Foundation. Dr. Mossad is experienced in emerging infectious diseases and has contributed to multiple publications related to infectious diseases in immunocompromised patients, including those undergoing stem cell transplants. His research has been published in journals such as Transplant Infectious Disease and Clinical Hematology International. He has also participated in clinical trials focusing on hematopoietic stem cell transplantation and influenza vaccination. Dr. Mossad received the CMS Meaningful Use Stage 1 Certification in 2011 and 2013.
Education & Training
- Cleveland Clinic FoundationFellowship, Infectious Disease, 1993 - 1996
- Cleveland Clinic FoundationResidency, Internal Medicine, 1990 - 1993
- Cairo University School of MedicineClass of 1987
Certifications & Licensure
- OH State Medical License 1993 - 2026
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Clinical Trials
- Influenza Vaccination in Bone Marrow Transplantation Start of enrollment: 2002 Oct 01
- Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Start of enrollment: 2015 Jun 01
Publications & Presentations
PubMed
- 1 citationsImpact of COVID-19 monoclonal antibodies on outcomes of COVID-19 infection in hematopoietic stem cell transplant and chimeric antigen receptor therapy recipients.Elizabeth H Hahn, Hong Li, Craig S Sauter, Sherif B Mossad
Transplant Infectious Disease. 2024-08-01 - 1 citationsEarly de-escalation of antibiotic therapy in hospitalized cellular therapy adult patients with febrile neutropenia.Mariana Lucena, Kelly J Gaffney, Theresa Urban, Catherine Forbes, Pavithra Srinivas
Clinical Hematology International. 2024-01-01 - Hey, Doc: Could the 2023-2024 cold and flu season finally be the calm after the storm?Sherif Beniameen Mossad
Cleveland Clinic Journal of Medicine. 2023-12-01
Journal Articles
- Training in Transplant Infectious Diseases: A Survey of Infectious Diseases and Transplant Infectious Diseases Fellows in the United States and CanadaSusanna K Tan, Sherif B Mossad, Nicole Theodoropoulos, Shirish Huprikar, Transplant Infectious Disease
Authored Content
- The perfect storm: An unseasonably early RSV annual epidemic, a severe annual flu epidemic, and a smoldering COVID-19 pandemicMay 2023
Press Mentions
- Preventing and Treating COVID-19 in Cancer Patients: Challenges in the Omicron EraMarch 10th, 2023
- Holidays May Bring More Flu as Virus Continues to SpreadDecember 20th, 2019
- ‘More Delay, Less Benefit’: Cleveland Clinic Doctor Encourages Public to Get Flu Vaccination EarlySeptember 12th, 2019
- Join now to see all
Grant Support
- Oseltamivir approval studyRochePresent
Committees
- Participant, ABIM infectious disease question writing taskforce
Research History
- Primary investigatorMulticenter studies: oseltamivir. Zoster vaccine, fidaxomicin. Retrospective studies: infectious complications in cancer and transplant patients
Professional Memberships
- Infectious disease society of AmericaFellow
Other Languages
- Arabic, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: